Literature DB >> 19655267

Evaluation of routine application of P504S, 34betaE12 and p63 immunostaining on 250 prostate needle biopsy specimens.

Kitty Pavlakis1, Konstantinos Stravodimos, Theodoros Kapetanakis, Alkiviadis Gregorakis, Sofia Athanassiadou, Olympia Tzaida, Constantinos Constantinides.   

Abstract

BACKGROUND: We aimed to determine whether a standard P504S, 34betaE12 and p63 immunostaining of prostate core needle biopsy specimens can optimize diagnostic accuracy of conventional staining methods.
MATERIALS AND METHODS: The staining properties of all three antibodies were evaluated on 250 prostate biopsies formerly diagnosed as benign.
RESULTS: Lack of basal cell staining in more than three glands for 34betaE12 and p63 occurred in 41 (27.5%) and 9 (6%) respective cases from the General Hospital pool. Respective figures from the Uropathology department specimens were 18 (18%) for 34betaE12 and 8 (8%) for p63. With the aid of P504S positivity, a case of prostate cancer as well as another of atypical small acinar proliferation was discovered.
CONCLUSION: Despite its potential for important aid in accurate diagnosis, standard application of immunohistochemistry in prostate biopsy is not justified and should be reserved for equivocal cases where conventional pathology fails to be conclusive.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19655267     DOI: 10.1007/s11255-009-9622-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  16 in total

1.  Loss of high-molecular-weight cytokeratin antigenicity in prostate tissue obtained by transurethral resections.

Authors:  H A Multhaupt; J N Fessler; M J Warhol
Journal:  Arch Pathol Lab Med       Date:  2000-12       Impact factor: 5.534

2.  Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.

Authors:  Rajal B Shah; Ming Zhou; Michele LeBlanc; Matthew Snyder; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2002-09       Impact factor: 6.394

3.  Use of p63/P504S monoclonal antibody cocktail in immunohistochemical staining of prostate tissue.

Authors:  David E Tacha; Rodney T Miller
Journal:  Appl Immunohistochem Mol Morphol       Date:  2004-03

4.  An analysis of the p63/alpha-methylacyl coenzyme A racemase immunohistochemical cocktail stain in prostate needle biopsy specimens and tissue microarrays.

Authors:  Schuyler O Sanderson; Thomas J Sebo; Linda M Murphy; Roxann Neumann; Jeff Slezak; John C Cheville
Journal:  Am J Clin Pathol       Date:  2004-02       Impact factor: 2.493

5.  Follow-up of atypical prostate needle biopsies suspicious for cancer.

Authors:  T Y Chan; J I Epstein
Journal:  Urology       Date:  1999-02       Impact factor: 2.649

6.  Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study.

Authors:  Victor WengLeong Ng; Magdalene Koh; Soo Yong Tan; Puay Hoon Tan
Journal:  Am J Clin Pathol       Date:  2007-02       Impact factor: 2.493

7.  Diagnostic utility of a p63/alpha-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy.

Authors:  Vincent Molinié; Jean Marie Hervé; Pierre Marie Lugagne; Thierry Lebret; Henry Botto
Journal:  BJU Int       Date:  2006-05       Impact factor: 5.588

8.  Monoclonal antibodies to human intermediate filament proteins. II. Distribution of filament proteins in normal human tissues.

Authors:  A M Gown; A M Vogel
Journal:  Am J Pathol       Date:  1984-02       Impact factor: 4.307

9.  Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases.

Authors:  K A Iczkowski; G T MacLennan; D G Bostwick
Journal:  Am J Surg Pathol       Date:  1997-12       Impact factor: 6.394

10.  Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate.

Authors:  Ximing J Yang; Chin-Lee Wu; Bruce A Woda; Karen Dresser; Maria Tretiakova; Gary R Fanger; Zhong Jiang
Journal:  Am J Surg Pathol       Date:  2002-07       Impact factor: 6.394

View more
  3 in total

1.  Expression of 34βE12 may be an independent predictor of survival in breast cancer.

Authors:  Chuchu Wang; Jiangguo Wei; Liming Huang; Chaoyang Xu
Journal:  J Int Med Res       Date:  2021-10       Impact factor: 1.671

2.  A comparative performance analysis of total PSA, percentage free PSA, PSA velocity, and PSA density versus the detection of primary circulating prostate cells in predicting initial prostate biopsy findings in Chilean men.

Authors:  Nigel P Murray; Eduardo Reyes; Nelson Orellana; Cynthia Fuentealba; Ricardo Dueñas
Journal:  Biomed Res Int       Date:  2014-07-01       Impact factor: 3.411

Review 3.  Prognostic histopathological and molecular markers on prostate cancer needle-biopsies: a review.

Authors:  A Marije Hoogland; Charlotte F Kweldam; Geert J L H van Leenders
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.